The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Novel Formulation Strategies for Improving Oral Bioavailability of Drugs with Poor Membrane Permeation or Presystemic Metabolism
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hidalgo, I. J., Raub, T. J., & Borchardt, R. T. (1989) · Gastroenterology · doi:10.1016/s0016-5085(89)80072-1 · Cited by 2,396
Artursson, P., & Karlsson, J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91647-u · Cited by 1,893
Pharmaceutical Applications of Solid Dispersion Systems
Chiou, W. L., & Riegelman, S. (1971) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600600902 · Cited by 1,799
Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency
Jani, P., Halbert, G. W., Langridge, J., & Florence, A. T. (1990) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1990.tb07033.x · Cited by 920
Caco-2 Cell Monolayers as a Model for Drug Transport Across the Intestinal Mucosa
Hilgers, A. R., Conradi, R. A., & Burton, P. S. (1990) · Pharmaceutical Research · doi:10.1023/a:1015937605100 · Cited by 587
Pappenheimer, J. R., & Reiss, K. Z. (1987) · The Journal of Membrane Biology · doi:10.1007/bf02209145 · Cited by 522
Structural basis for physiological regulation of paracellular pathways in intestinal epithelia
Madara, J. L., & Pappenheimer, J. R. (1987) · The Journal of Membrane Biology · doi:10.1007/bf02209147 · Cited by 513
Damgé, C., Michel, C., Aprahamian, M., & Couvreur, P. (1988) · Diabetes · doi:10.2337/diab.37.2.246 · Cited by 390
(C) Means to enhance penetration
Scott Swenson, E., & Curatolo, W. J. (1992) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(92)90015-i · Cited by 314
Aungst, B. J., J. Rogers, N., & Shefter, E. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90057-8 · Cited by 306
Self-citation
Cited by
Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs
Neslihan Gursoy, R., & Benita, S. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2004.02.001 · Cited by 1,358
Role of P-Glycoprotein in Pharmacokinetics: Clinical Implications
Lin, J. H., & Yamazaki, M. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342010-00003 · Cited by 998
Nanosuspensions: a promising drug delivery strategy
Patravale, V. B., Date, A. A., & Kulkarni, R. M. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023691 · Cited by 904
Chitosan-based gastrointestinal delivery systems
Hejazi, R., & Amiji, M. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00126-3 · Cited by 882
Development and bioavailability assessment of ramipril nanoemulsion formulation
Shafiq, S., Shakeel, F., Talegaonkar, S., Ahmad, F. J., Khar, R. K., & Ali, M. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.10.014 · Cited by 817
Role of Pharmacokinetics and Metabolism in Drug Discovery and Development
Lin, J. H., & Lu, A. Y. H. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01340-1 · Cited by 708
Oral drug absorption enhancement by chitosan and its derivatives
Thanou, M., Verhoef, J. C., & Junginger, H. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00231-9 · Cited by 689
Kommuru, T. R., Gurley, B., Khan, M. A., & Reddy, I. K. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00614-1 · Cited by 624
Charman, W. N., Porter, C. J. H., Mithani, S., & Dressman, J. B. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960085v · Cited by 617
Lipid-based vehicles for the oral delivery of poorly water soluble drugs
Humberstone, A. J., & Charman, W. N. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00494-2 · Cited by 577
Drugs: A review of promising novel corrosion inhibitors
Gece, G. (2011) · Corrosion Science · doi:10.1016/j.corsci.2011.08.006 · Cited by 565
Kang, B. K., Lee, J. S., Chon, S. K., Jeong, S. Y., Yuk, S. H., Khang, G., Lee, H. B., & Cho, S. H. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.12.028 · Cited by 545
Oral Delivery of Peptide Drugs: Barriers and Developments
Hamman, J. H., Enslin, G. M., & Kotz??, A. F. (2005) · BioDrugs · doi:10.2165/00063030-200519030-00003 · Cited by 499
Oral lipid-based drug delivery systems – an overview
Kalepu, S., Manthina, M., & Padavala, V. (2013) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2013.10.001 · Cited by 494
Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs
Gershanik, T. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00089-8 · Cited by 477
Chitosan and its derivatives as intestinal absorption enhancers
Thanou, M., Verhoef, J. C., & Junginger, H. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00180-6 · Cited by 430
50 years of oral lipid-based formulations: provenance, progress and future perspectives
Feeney, O. M., Crum, M. F., McEvoy, C. L., Trevaskis, N. L., Williams, H. D., Pouton, C. W., Charman, W. N., Bergström, C. A. S., & Porter, C. J. H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.007 · Cited by 426
Lipid – An emerging platform for oral delivery of drugs with poor bioavailability
Chakraborty, S., Shukla, D., Mishra, B., & Singh, S. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.06.001 · Cited by 411
Son, G.-H., Lee, B.-J., & Cho, C.-W. (2017) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0320-1 · Cited by 320
Amorphous Drug Delivery Systems: Molecular Aspects, Design, and Performance
Kaushal, A. M., Gupta, P., & Bansal, A. K. (2004) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v21.i3.10 · Cited by 312
Active secretion and enterocytic drug metabolism barriers to drug absorption
Wacher, V. J., Salphati, L., & Benet, L. Z. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00127-s · Cited by 308
Microemulsions: A Novel Approach to Enhanced Drug Delivery
Talegaonkar, S., Azeem, A., Ahmad, F., Khar, R., Pathan, S., & Khan, Z. (2008) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221108786241679 · Cited by 303
Hunter, J., & Hirst, B. H. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00497-3 · Cited by 291
Intestinal lymphatic transport for drug delivery
Yáñez, J. A., Wang, S. W. J., Knemeyer, I. W., Wirth, M. A., & Alton, K. B. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.019 · Cited by 278
Wu, Y., Loper, A., Landis, E., Hettrick, L., Novak, L., Lynn, K., Chen, C., Thompson, K., Higgins, R., Batra, U., et al. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.08.001 · Cited by 275
Chen, Y., Lu, Y., Chen, J., Lai, J., Sun, J., Hu, F., & Wu, W. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.022 · Cited by 274
Mayer, U., Wagenaar, E., Dorobek, B., Beijnen, J. H., Borst, P., & Schinkel, A. H. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119784 · Cited by 269
Lipid-based nanocarriers for oral peptide delivery
Niu, Z., Conejos-Sánchez, I., Griffin, B. T., O’Driscoll, C. M., & Alonso, M. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.001 · Cited by 265
Khan, A. W., Kotta, S., Ansari, S. H., Sharma, R. K., & Ali, J. (2015) · Drug Delivery · doi:10.3109/10717544.2013.878003 · Cited by 253
Preparation, characterization, and pharmacokinetics of liposomal docetaxel for oral administration
Kim, J. H., Shin, D. H., & Kim, J.-S. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1046-y · Cited by 37
Metadata
- Authors
- Aungst, B. J.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 1993-10
- Volume
- 82
- Issue
- 10
- Pages
- 979-987
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W1965845975
- Cited by
- 294
- References
- 59
- FWCI
- 3.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.